As a subsidiary of Samyang Holdings to advance its biopharmaceutical business into international markets, Samyang Biopharm USA, Inc. was established in October 2018 in Boston, Massachusetts, the U.S. We are building a network with biopharmaceutical and bioengineering drug companies, startups, hospitals, and universities in Boston for development of new biopharmaceutical technologies and drug discovery of new candidates. Furthermore, we take the lead in conducting global clinical trials for anti-cancer drug candidates researched by Samyang Holdings and make efforts to improve the speed and success rate of the biopharmaceutical drug development.